 |
Previous Article | Next Article 
The Journal of Neuroscience, April 1, 2003, 23(7):2675
Identification and Characterization of Aplysia
Adducin, an Aplysia Cytoskeletal Protein Homologous to
Mammalian Adducins: Increased Phosphorylation at a Protein Kinase C
Consensus Site during Long-Term Synaptic Facilitation
Lore M.
Gruenbaum1,
Diana M.
Gilligan2,
Marina
R.
Picciotto3,
Stéphane
Marinesco4, and
Thomas J.
Carew4
1 Boehringer Ingelheim Pharmaceuticals, Ridgefield,
Connecticut 06877, 2 Puget Sound Blood Center, Seattle,
Washington 98104, 3 Department of Psychiatry, Yale
University School of Medicine, New Haven, Connecticut 06508, and
4 Department of Neurobiology and Behavior, Center for
Learning and Memory, University of California, Irvine, California
92697-4550
 |
ABSTRACT |
Structural changes at synapses are associated with
long-term facilitation (LTF) of synaptic transmission between sensory
and motor neurons in Aplysia. We have cloned a cDNA
encoding Aplysia adducin (ApADD), the
Aplysia homolog of mammalian adducins that are
regulatory components of the membrane cytoskeleton. ApADD is recovered
in the particulate fraction of nervous system extracts and is localized
predominantly in the submembraneous region of Aplysia
neurons. ApADD is phosphorylated in vitro by protein
kinase C (PKC) at a site homologous to the in vivo PKC
phosphorylation site in mammalian adducins. Phosphorylation of ApADD at
this site is also detected in vivo in the intact
Aplysia nervous system and is increased 18 hr after
serotonin-induced LTF. In contrast, there is no change in
phosphorylation during short-term facilitation or 1 hr after initial
LTF induction. Thus, ApADD is modulated specifically with later phases
of LTF and provides an attractive candidate protein that contributes to
structural changes accompanying long-lasting synaptic alteration.
Key words:
adducins; protein kinase C; long-term facilitation; cytoskeleton; synaptic plasticity; serotonin
 |
Introduction |
Morphological changes in the brain
are associated with plastic processes leading to long-term memory and
may be a critical mechanism for maintaining learning-associated
synaptic changes. For example, long-term potentiation (LTP) leads to
the formation of new spines on postsynaptic hippocampal dendrites and
the appearance of multiple spine synapses between a single axon
terminal and a dendrite (Engert and Bonhoeffer, 1999 ; Klintsova and
Greenough, 1999 ; Maletic-Savatic et al., 1999 ; Toni et al., 1999 ;
Bonhoeffer and Yuste, 2002 ). In addition, synapse density is increased
in the hippocampus of mice that are exposed to an enriched environment (Rampon et al., 2000 ). Finally, in Aplysia californica, the
formation of long-term memory is accompanied by an increase in the
number of synaptic active zones and presynaptic varicosities and by the growth of new presynaptic branches (Bailey and Chen, 1988 ; Bailey and
Kandel, 1994 ; Wainwright et al., 2002 ).
Synaptic remodeling that accompanies learning requires alterations of
the cytoskeleton at the site of growth, but the molecular mechanisms
underlying those alterations have been difficult to identify. It is
believed that the initial step in these structural changes involves a
loss of cytoskeletal rigidity, allowing remodeling of synaptic
contacts. At least two proteins have been implicated in this first
step: (1) cell-adhesion molecules (CAMs) that link the plasma membrane
to the extracellular matrix and are endocytosed during long-term
facilitation (LTF) probably to be degraded (Bailey et al., 1992 ;
Mayford et al., 1992 ) and (2) microtubule-associated protein 2 (MAP 2),
which unbinds microtubules during phosphorylation, thus destabilizing
the cytoskeleton (Audesirk et al., 1997 ; for review, see Sanchez et
al., 2000 ). A particularly interesting set of cytoskeletal proteins are
the adducins, which provide a link between signaling cascades and cell
structure. Adducins cross-link actin filaments with spectrin, cap the
barbed end of actin filaments, and bundle actin filaments (Gardner and
Bennett, 1987 ; Mische et al., 1987 ; Kuhlman et al., 1996 ). Both
phosphorylation of adducins by PKC and calcium/calmodulin binding
inhibit the actin-capping and spectrin-recruitment properties of
adducins (Gardner and Bennett, 1987 ; Kuhlman et al., 1996 ; Matsuoka et
al., 1996 , 1998 ). Mammalian adducins are encoded by three genes ( ,
, and ) (Joshi et al., 1991 ; Suriyapperuma et al., 2000 ), and
 or  heterodimers appear to be the predominant active
isoforms (Hughes and Bennett, 1995 ; Gilligan et al., 1999 ). Adducins
have been implicated in structural change in numerous cell types
(Waseem and Palfrey, 1988 , 1990 ; Kaiser et al., 1989 ; Yue and
Spradling, 1992 ; Fukata et al., 1999 ; Gilligan et al., 2002 ). They are
expressed throughout the brain in regions that are rich in synaptic
contacts (Seidel et al., 1995 ), and the phosphorylated form of adducin
(phospho-adducin) is detected in the dendrites of hippocampal neurons
(Matsuoka et al., 1998 ). Thus, the adducins represent a family of
proteins that are ideal candidates to translate a complex interplay of signaling cascades into a localized change in cytoskeletal structure accompanying long-term synaptic plasticity.
Any morphological change in a neuron requires an alteration of the
cytoskeletal architecture of the cell. To identify the cytoskeletal
elements underlying such changes, we have taken advantage of a simple
model system, the marine mollusk Aplysia, for which the
neural correlates of memory have been extensively examined and can be
studied in the intact nervous system. Sensitization of the gill and
siphon withdrawal reflexes in Aplysia involves the
facilitation of neurotransmission at identified synapses between sensory neurons (SNs) and motor neurons (MNs) (Frost et al., 1985 ). The
cellular features of sensitization are mimicked in a reduced preparation of the Aplysia nervous system by the direct
application of serotonin (5-HT), which is released in the CNS after
sensitizing stimuli (Levenson et al., 1999 ; Marinesco and Carew, 2002 ).
Sensitization, as well as synaptic facilitation induced by 5-HT, can
exist in short-term, intermediate-term, and long-term forms (Carew et
al., 1971 ; Pinsker et al., 1973 ; Emptage and Carew, 1993 ; Ghirardi et
al., 1995 ; Sutton and Carew, 2000 ). In contrast to short-term facilitation (STF), LTF requires changes in gene expression and is
associated with changes in synaptic structure (Montarolo et al., 1986 ;
Castellucci et al., 1989 ; Bailey and Kandel, 1994 ; Martin et al.,
1997 ). In this study, we first characterized Aplysia adducin
(ApADD), the Aplysia homolog of mammalian adducins, and then
analyzed how it is modulated during forms of synaptic plasticity that
are cellular correlates of memory in Aplysia. ApADD is
localized to the submembraneous compartment of neurons involved in
synaptic facilitation and is phosphorylated by PKC in vitro
and in vivo. Using the intact Aplysia nervous
system and procedures shown previously to induce LTF (Montarolo et al.,
1986 ; Emptage and Carew, 1993 ; Ghirardi et al., 1995 ), we found that
phosphorylation of ApADD at a PKC consensus site is increased 18 hr
after initial LTF induction. Our data suggest that ApADD contributes to
later phases of LTF and may participate in structural changes during
LTF that are a common feature of long-term synaptic plasticity and memory.
 |
Materials and Methods |
PCR homology screening. A PCR homology screen was
performed using pools of inosine-containing oligonucleotides as primers and a ZAPII cDNA library from the Aplysia nervous system
as a template (gift from Wayne Sossin, McGill University, Montreal, Canada). Oligonucleotides were designed using a multiple alignment of
Drosophila and mammalian adducin amino acid sequences. Amino acid regions with high similarity between adducin species were identified, and primers corresponding to two sequences (amino acids
309-315 and 386-392 of human -adducin) were used successfully for
PCR. The primer sequences were GA(AG) ACI (AG)TI GA(AG) GCI TT and GTI
C(GT)(AG) TAI CCI (AG)I(AG) TT(AG) TC.
Cloning and plasmids. A ZAPII cDNA library was screened
under high-stringency conditions with the 242 bp ApADD probe obtained via PCR (see above) (Sambrook et al., 1989 ). Positive plaques were
replated and rescreened, and plaques that remained positive through
three screenings were isolated. pBluescriptII phagemids were excised
from the ZAPII vector in vivo with ExAssist helper phage,
and plasmid inserts were sequenced. One clone contained a complete open
reading frame encoding ApADD (GenBank accession number
AY191225).
Three vectors were constructed for the expression of recombinant
polyhistidine-ApADD fusion proteins in bacteria. cDNAs, encoding full-length ApADD (FL; amino acids 1-701), the predicted N-terminal domain (NT) (amino acids 1-350), and the C-terminal domain of ApADD
(CT) (amino acids 351-701) were amplified by PCR. PCR primers for the three cDNAs contained additional NdeI and
BamHI sites for subcloning. All three cDNAs were subcloned
first into a dT-tailed vector (TA Cloning Kit; Invitrogen,
Carlsbad, CA) and after NdeI-BamHI restriction into the NdeI-BamHI cloning sites of
the pET-19b vector. This vector allows bacterial expression of
recombinant proteins with an N-terminal tag consisting of six histidine
(His) residues.
Recombinant ApADD protein expression and preparation of
Aplysia tissues homogenates. Polyhistidine-adducin
constructs were transformed into Escherichia coli (BL21),
and the expression of the recombinant His-ApADD fusion proteins was
induced with isopropyl- -D-thiogalactopyranoside (IPTG)
(1 mM) according to the pET system manual
(Novagen, Madison, WI). Recombinant proteins were purified
from bacterial cultures under native conditions using the TALON Cell
Thru metal affinity resin (Clontech User Manual; Clontech,
Cambridge, UK).
Wild-caught adult Aplysia californica (~150 gm; purchased
from Marinus, Long Beach, CA) were anesthetized by injection of isotonic MgCl2 (~100 ml/100 gm body weight).
Ganglia and other tissues were removed immediately and homogenized in a
glass homogenizer on ice in SDS sample buffer unless indicated otherwise.
Triton X-100 extraction of Aplysia ApADD.
Pleural-pedal ganglia were rinsed twice and homogenized in cold PBS
containing 5 mM EGTA and 4 mM Pefabloc (broad range protease inhibitor) in the presence of 0, 0.1, or 1% Triton X-100. Insoluble proteins in the
particulate fraction were pelleted by centrifugation (100,000 × g for 30 min) and resuspended in a volume equal to that of
the soluble cytosolic fraction.
Phosphatase treatment of Aplysia pleural-pedal
homogenates. Pleural-pedal ganglia were homogenized in 10 mM Tris-HCl, pH 7.5, in the presence
of 4 mM Pefabloc. Mixtures for phosphatase
and mock treatment contained (in mM): 20 MgCl2, 100 NaCl, and 0.5 EGTA. In addition, mock
mixtures contained 20 mM NaF and 20 mM -glycerophosphate, whereas
phosphatase mixtures contained 2 U of calf intestinal phosphatase
(Sigma, St. Louis, MO). Mixtures were added to 40 µg
pleural-pedal homogenate and incubated at 37°C for 30 min. Reactions
were terminated by the addition of SDS sample buffer.
In vitro phosphorylation of recombinant ApADD proteins with
PKC. Purified recombinant His-ApADD fusion proteins (FL, NT, and CT; 10 µg each) were phosphorylated by incubation with 0.1 mM ATP, 5 mM
MgCl2, 1 mM EGTA, 50 mM Tris-HCl, pH 7.5, and 2.5 µg/ml rat brain
PKC (Calbiochem, La Jolla, CA) at room temperature for 2 hr. The reaction was terminated by the addition of SDS sample buffer.
Antisera. A phospho-adducin antiserum (Upstate
Biotechnology, Lake Placid, NY) was raised against a
phosphopeptide corresponding to amino acids 656-668 of human
-adducin [KKFRTP(pS)FLKKNK]. General adducin antisera were raised
in rabbits against synthetic peptides corresponding to various regions
of human - and -adducins (Gilligan et al., 2002 ). These peptide
sequences are conserved between mammalian and Aplysia
adducins. The antibody referred to as "adducin antibody" was
affinity-purified using recombinant human -adducin coupled to
cyanogen bromide-activated Sepharose (Gilligan et al., 2002 ). This
antibody recognizes human -, -, and -adducin via a C-terminal
epitope. Where indicated, another antiserum was affinity-purified
against synthetic peptides corresponding to mammalian adducin
sequences. This antibody reacts with both N-terminal and C-terminal
epitopes. In one experiment, an antibody was used that had been
affinity-purified against human recombinant -adducin (Gilligan et
al., 1999 ).
Western blot analysis and immunocytochemistry. Homogenates
of Aplysia ganglia (20 µg) were separated on 8-15%
SDS-polyacrylamide gradient gels and transferred to nitrocellulose
membranes. Membranes were blocked with 4% BSA and probed with adducin
or phospho-adducin antibodies followed by protein A-HRP
(BioRad, Hercules, CA). Adducin signals were visualized by
enhanced chemiluminescence (Renaissance; NEN, Boston, MA).
Pleural-pedal ganglia were desheathed and fixed in 4%
paraformaldehyde, PBS, and 20% sucrose overnight at 4°C. Ganglia
were washed three times for 15 min in PBS, permeabilized for 1 hr in 4% Triton X-100/PBS, rinsed in PBS, and blocked in 2% normal goat serum for 1 hr at room temperature. Ganglia were incubated with adducin
antibody affinity-purified against human recombinant -adducin (0.5 mg/ml; 1:10000 in blocking medium) for 2 d at 4°C, washed three
times for 15 min in PBS, and kept in goat anti-rabbit-Alexa-Fluor 488 (Molecular Probes, Eugene, OR) (1:100 in blocking medium) for 2.5 hr at room temperature. After three washes in PBS, ganglia were
mounted in Citifluor, and immunoreactivity was visualized using a
BioRad MRC 1020 confocal microscope with a krypton/argon laser. Images were collected using LaserSharp imaging software.
Ganglia preparation for 5-HT stimulation. Pleural-pedal
ganglia were removed from Aplysia immediately after
anesthesia and transferred to Sylgard-coated recording dishes
containing a 1:1 mixture of isotonic MgCl2 and
artificial sea water (ASW) containing (in
mM): 460 NaCl, 55 MgCl2, 11 CaCl2, 10 KCl, and 10 Tris, pH 7.6, to prevent
synaptic transmission during dissection. Ganglia were pinned down and
desheathed so that somatic clusters of tail SNs in the pleural and tail
MNs in the pedal ganglia were exposed. After dissection, preparations
were continuously perfused at a rate of 5 ml/min at room temperature
with ASW or 5-HT (50 µM) dissolved in ASW. In
stimulation experiments, one of the paired pleural-pedal ganglia from
each animal was used as an internal control and perfused with ASW only.
To investigate the modulation of ApADD after STF, preparations were
stimulated with a single 5 min pulse of 5-HT. To analyze the modulation
of ApADD after the induction of LTF, preparations received five spaced
5 min pulses of 5-HT (10 min between pulses).
Quantitation of ApADD and phospho-ApADD levels in Aplysia
ganglia. The amount of protein, total ApADD, and
phospho-ApADD in each sample was determined from densitometric scans of
Coomassie-stained gels or Western blot analysis. Western blots were
exposed for different time intervals, and multiple exposures were
scanned and analyzed for each blot to ensure that the obtained signals were not saturated. For each ganglion sample, the ApADD or
phospho-ApADD signal was normalized to the total protein content.
Phospho-ApADD signals were also normalized to total adducin signals in
the same samples as indicated. Finally, the means obtained for the
control groups (unstimulated ganglia) were set to 1.
All data in the experiments on synaptic facilitation were normally
distributed. Comparisons between control and 5-HT-treated ganglia were
performed using Student's unpaired t test. The difference between mean values was regarded as statistically significant if
p < 0.05.
 |
Results |
Cloning of a cDNA encoding ApADD
We generated an alignment of available vertebrate and invertebrate
adducin amino acid sequences to identify regions that are highly
conserved between species. Conserved amino acid sequences were selected
to design pools of degenerate inosine-containing oligonucleotides.
These oligonucleotides were used as primers in a PCR homology screen
with a cDNA library from the Aplysia nervous system as a
template. One primer pair (corresponding to amino acids 309-315 and
386-392 of human -adducin) amplified a 242 bp DNA fragment that was
cloned and sequenced. The deduced amino acid sequence of this clone was
58% identical to human -adducin. Therefore, we used this 242 bp DNA
fragment to screen an Aplysia nervous system cDNA library
under high-stringency conditions. One of the clones identified in this
screen contained an open reading frame encoding a putative polypeptide
of 701 amino acids (calculated molecular weight: 77.4 kDa) (Fig.
1A). The polypeptide shows sequence homology to Drosophila (43% identity, 62%
similarity with the Drosophila adducin homolog R1) and
mammalian (42% identity with human -adducin) adducin and was named
ApADD. Regions of high similarity to invertebrate and vertebrate
adducins exist throughout the ApADD sequence (Fig.
1A,B), but similarity is highest in
the region corresponding to the N-terminal head domain of adducins (amino acids 1-336, 50% identity with human -adducin). This region also shows the highest conservation between different mammalian adducins. Like other adducin family members, ApADD also contains a
C-terminal highly basic domain with sequence similarity to the mammalian myristoylated alanine-rich C kinase substrate (MARCKS) protein (Joshi et al., 1991 ; Dong et al., 1995 ) (amino acids 675-685 in ApADD have 48% identity with the corresponding sequence in chicken
MARCKS). A serine residue (Ser 668 of human -adducin) within the
MARCKS-related domain was characterized previously as a major in
vitro and in vivo PKC phosphorylation site for
mammalian adducins (Dong et al., 1995 ; Matsuoka et al., 1998 ). This
site is conserved in ApADD (FRMPSF, amino acids 683-688),
suggesting that it may be a target for PKC phosphorylation.

View larger version (97K):
[in this window]
[in a new window]
|
Figure 1.
ApADD resembles other adducin family members.
A, An alignment of the deduced ApADD amino acid sequence
with human, mouse, and Drosophila adducins was created
using the Clustal Method (MegAlign; DNAStar, Madison, WI). Amino acids
that are identical between species are boxed in
black. The arrowhead indicates the
in vivo PKC phosphorylation site in the MARCKS domain of
mammalian adducins. This site is conserved in ApADD and recognized by
the phospho-adducin specific antibody. B, Comparison
between ApADD and predicted polypeptides with adducin homology in
C. elegans and S.
pombe. A region from the N-terminal domain of ApADD was
aligned with deduced amino acid sequences from C.
elegans (cosmids F39C12 and F57F5) and S.
pombe (GenBank accession numbers O42892 and
Q9P5M9).
|
|
Like mammalian adducins, ApADD has a highly hydrophilic
C-terminal domain
The strong similarity of ApADD to mammalian adducins suggests that
ApADD has a similar domain structure with distinct N-terminal and
C-terminal domains. We expressed full-length ApADD and polypeptides corresponding to its predicted N-terminal and C-terminal domains as fusion proteins with an N-terminal tag of six histidine residues in
bacteria. The recombinant proteins were purified via nickel chelate
chromatography (Fig.
2A). The
electrophoretic migration of the NT protein was consistent with the
molecular weight calculated from its amino acid sequence (49 kDa). In
contrast, the relative mobilities of FL and CT were higher than the
molecular weight calculated from the amino acid sequences (FL,
Mr 100 vs 80 kDa calculated; CT,
Mr 50 vs 35 kDa calculated). This anomalous
electrophoretic migration has also been observed for mammalian adducins
and is most likely attributable to the strong hydrophilicity of
the C-terminal domain (Joshi et al., 1991 ). The hydrophilicity profile
of ApADD shows that the predicted C-terminal domain of ApADD (amino
acids 335-701) is highly enriched in hydrophilic residues, whereas the N-terminal domain contains both hydrophilic and hydrophobic residues (Fig. 2B). Therefore, ApADD and mammalian adducins
share a common hydrophilicity profile.

View larger version (74K):
[in this window]
[in a new window]
|
Figure 2.
Recombinant ApADD proteins are recognized by
antibodies against mammalian adducins and show anomalous
electrophoretic mobility. A, Full-length ApADD (amino
acids 1-701) and its predicted N-terminal (amino acids 1-350) and
C-terminal domains (amino acids 351-701) were expressed with an
N-terminal tag of six histidine residues in bacteria. Recombinant
proteins were purified from bacterial homogenates
(H) via nickel chelate chromatography
(F, flow-through from affinity column; E,
eluate-containing recombinant proteins). B,
Hydrophilicity profiles of human -adducin and Aplysia
adducin ApADD. The profiles were generated using the
Kyte-Doolittle algorithm within the program Protean
(DNAStar). C, FL, NT, and CT ApADD
were expressed with an N-terminal tag of six histidine residues in
bacteria. Samples were taken from each bacterial culture immediately
before the induction of expression with 1 mM IPTG ( ) and
4 hr after induction (+). Homogenate from Aplysia
pleural-pedal ganglia (Ap) was processed in parallel.
For all samples, equal amounts of protein were separated by SDS-PAGE.
Gels were stained with Coomassie Blue or blotted onto nitrocelluose and
probed with adducin antibody that had been affinity-purified against
-adducin and reacts with C-terminal adducin epitopes, anti-adducin
(CT), or with adducin antibody that had been purified against synthetic
peptides and reacts with N-terminal and C-terminal adducin epitopes
(anti-adducin, NT plus CT peptides).
|
|
ApADD is expressed in Aplysia nervous system
To gain tools for the analysis of ApADD function, we tested
antibodies raised against synthetic peptides derived from human adducins for cross-reactivity with recombinant ApADD proteins. We used
two different antibodies affinity-purified against recombinant human
-adducin [anti-adducin (CT)] or against synthetic peptides (anti-adducin, NT plus CT peptides) (Gilligan et al., 1999 ). Both antibodies cross-react with human and mouse -, -, and -adducin (D. Gilligan, unpublished observations).
The antibody affinity-purified against recombinant -adducin
reacts with FL and CT but not with NT ApADD (Fig. 2C,
middle). This antibody also recognizes C-terminal epitopes
in mammalian adducins (D. Gilligan, unpublished observations). The
antibody affinity-purified against synthetic peptides recognizes FL,
NT, and CT ApADD (Fig. 2C, bottom).
Both antibodies also strongly cross-react with a polypeptide of ~100
kDa in extracts from Aplysia nervous system (Figs.
2C, Ap,
3A, adducin/Ap).
This endogenous Aplysia polypeptide co-migrates with
recombinant FL ApADD and with adducins detected in human red blood cell
(RBC) ghosts (Figs. 2C, 3A). A comparable
endogenous Aplysia protein is also detected with adducin
antibody affinity-purified against human recombinant -adducin (Fig.
3A, /Ap). This antibody reacts preferentially with
mammalian -adducin (D. Gilligan, unpublished observations).
Therefore, we conclude that the antibodies against mammalian adducins
cross-react with ApADD in Aplysia tissues.

View larger version (36K):
[in this window]
[in a new window]
|
Figure 3.
ApADD is expressed in Aplysia
tissues. A, Western blot analysis of homogenates from
Aplysia pleural-pedal ganglia. Human red blood cell
(RBC) ghosts and pleural-pedal homogenates
(Ap) were separated by SDS-PAGE, electroblotted, and
probed with adducin antibody affinity-purified against human
recombinant -adducin (adducin) or human recombinant
-adducin (beta), or with the phospho-adducin specific
antibody (phospho). B, ApADD
expression in different Aplysia tissues. Human RBC
ghosts (lane1), as well as homogenates from
Aplysia pleural-pedal ganglia (lane 2),
abdominal ganglia (lane 3), skin (lane
4), buccal mass (lane 5), penis
(lane 6), heart (lane 7),
hepatopancreas (lane 8), and body wall (lane
9) were separated by SDS-PAGE, electroblotted, and probed with
anti-adducin antibody affinity-purified against human recombinant
-adducin.
|
|
All adducin antibodies also react with a polypeptide of a relative
mobility of ~50 kDa in Aplysia homogenates. This
polypeptide is not detected in RBCs and may be a product of regulated
proteolysis, an alternatively spliced form of ApADD, or the gene
product of a different adducin gene in Aplysia. Regulated
proteolysis and alternative splicing have been described for mammalian
adducins (Lin et al., 1995 ; Gilligan et al., 1997 ; Sinard et al.,
1998 ). However, we cannot entirely exclude the possibility that the 50 kDa polypeptide is an artifact that may have been generated during sample processing.
Western blot analysis of extracts from different Aplysia
tissues shows that ApADD is expressed in skin, body wall, buccal mass,
heart, hepatopancreas, and penis (Fig. 3B). This broad
expression is consistent with the ubiquitous expression pattern found
for mouse - and -adducin (Gilligan et al., 1999 ).
ApADD is recovered in the particulate fraction of nervous system
extracts and is localized in the submembraneous region of neurons
To analyze the subcellular distribution of ApADD, we generated
particulate and cytosolic fractions of Aplysia nervous
system extracts and performed Western blot analysis with adducin and phospho-adducin antibodies on these fractions. Approximately 95% of
total and phosphorylated ApADD are recovered in the particulate fraction (Fig. 4). This is consistent
with the localization of mammalian adducins to the cytoskeleton- and
membrane-containing cellular components. To investigate additional
similarities with mammalian adducins, we examined the extraction of
ApADD from the particulate fraction with increasing concentrations of
nonionic detergent (Triton X-100). After fractionation in the presence of 0.1% Triton X-100, a strong ApADD signal was detected in the soluble fraction (43% of total signal in soluble fraction). Extraction of ApADD was slightly increased in the presence of 1% Triton X-100 (54% of total adducin soluble) (Fig. 4). A partial extraction with
nonionic detergent has also been described for mammalian adducins
(Waseem and Palfrey, 1988 ). Phospho-ApADD shows extractability similar to ApADD. Treatment with 1% Triton X-100 leads to a slightly better extraction of phospho-ApADD compared with total ApADD (66% of
total phospho-ApADD soluble; data not shown).

View larger version (27K):
[in this window]
[in a new window]
|
Figure 4.
Subcellular distribution and extraction properties
of ApADD. Crude particulate fractions (P) and
cytosolic fractions (S) were prepared from
Aplysia pleural-pedal ganglia in the absence ( ) or
presence of nonionic detergent (Triton X-100, 0.1 or 1%). Sample
processing as described previously for Figure 3B.
|
|
To study further the cellular and subcellular localization of ApADD, we
analyzed whole-mount preparations of pleural-pedal ganglia by
immunofluorescence microscopy using affinity-purified adducin antibody.
ApADD immunoreactivity was high in the majority of neuronal cell bodies
but excluded from the nuclei (Fig.
5A-C). Maximum signals were
detected in a region just underneath the plasma membrane in all neurons
observed (Fig. 5A,B, pleural SNs, C, pedal neurons). Only weak fluorescence was detected
throughout the cytoplasmatic area of cells when adducin antibodies were
replaced by nonimmune IgG or omitted entirely (data not shown). These
results strongly support our hypothesis that ApADD is localized to the membrane cytoskeleton of Aplysia neurons.

View larger version (46K):
[in this window]
[in a new window]
|
Figure 5.
ApADD immunoreactivity in pleural-pedal ganglia.
ApADD immunoreactivity in pleural and pedal ganglia. Immunostaining was
performed in whole-mount preparations from desheathed pleural and pedal
ganglia, using adducin antiserum that had been affinity-purified
against human recombinant -adducin. The tail sensory neurons in the
pleural ganglion show somatic ApADD immunoreactivity localized to the
cytoplasm (A) and close to the plasma membrane
(B, higher magnification). ApADD immunoreactivity is
also found in neurons within the pedal ganglion
(C). Scale bar, 100 µm.
|
|
ApADD is phosphorylated by PKC in vitro and
in vivo
A 100 kDa polypeptide was also recognized in Aplysia
nervous system extracts by a phospho-adducin-specific antibody raised against a phospho-peptide corresponding to the major
PKC-phosphorylation site in mammalian adducins (Fig. 3A).
The sequence around this PKC phosphorylation site is highly conserved
among mammalian adducins as well as in ApADD (Fig.
1A).
To confirm that ApADD is in fact a PKC substrate, we performed in
vitro phosphorylation of recombinant ApADD FL, NT, and CT polypeptides with purified active PKC from rat brain
(Calbiochem, La Jolla, CA). We analyzed the
phosphorylation of ApADD proteins by Western blot analysis with the
phospho-adducin antibody. In the absence of PKC, none of the
recombinant ApADD polypeptides was phosphorylated to a significant
degree ( ). Incubation with PKC (+) led to a strong phospho-signal for
the FL and CT proteins but not to an increase in the signal for the NT
protein (Fig. 6A). None
of the three proteins were degraded during incubation with PKC because
they remained detectable with adducin antibody affinity-purified
against adducin peptides. This finding confirms that the C-terminal
domain of ApADD is phosphorylated by PKC. Because PKC phosphorylation
of ApADD is detectable with an antibody specific for the in
vivo PKC site in mammalian adducins, we conclude that the
corresponding site may also be phosphorylated by PKC in
Aplysia.

View larger version (32K):
[in this window]
[in a new window]
|
Figure 6.
ApADD is phosphorylated by PKC. A,
Recombinant ApADD proteins (FL, NT, and
CT; see Fig. 2A) were
phosphorylated in the absence ( ) or presence (+) of rat brain PKC
in vitro. Reactions were terminated by the addition of
SDS sample buffer and samples were submitted to Western blot analysis
with adducin antibody affinity-purified against adducin peptides or
with phospho-adducin-specific antibody. B, Western blot
analysis of pleural-pedal homogenates exposed to calf intestinal
alkaline phosphatase (AP) or mock treatment
(M). Samples were probed with
phospho-adducin antibody and adducin antibody affinity-purified against
human recombinant -adducin.
|
|
We also tested the specificity of the phospho-adducin-specific antibody
in Aplysia tissue extract. Treatment of tissue extract with
alkaline phosphatase (AP) but not mock treatment (M) abolished the
signal detected with the phospho-adducin antibody. Total ApADD as
detected with adducin antibody remained unchanged (Fig.
6B). This finding confirms that ApADD is
phosphorylated at a PKC site in Aplysia nervous tissue and
that the phospho-adducin antibody can be used to detect changes in the
phosphorylation of this site.
PKC phosphorylation of ApADD is increased with multiple exposures
to 5-HT that give rise to long-term facilitation of SN-MN synapses
To determine a possible role of ApADD in structural changes
associated with synaptic plasticity, we examined ApADD expression and
phosphorylation by PKC following procedures that induce STF and LTF.
Facilitation was induced by direct application of 5-HT to the intact
nervous system containing the presynaptic SN cell bodies and proximal
synapses in the pleural ganglion and the SN-MN synapses and MN cell
bodies in the pedal ganglion (Emptage and Carew, 1993 ; Mauelshagen et
al.,1996 ; Sherff and Carew, 1999 ). For each animal, one ganglion pair
was exposed to 5-HT, whereas the ganglia from the opposite side of the
body served as an unstimulated control. Pleural and pedal ganglia were
homogenized separately in SDS sample buffer, and total ApADD and
phospho-ApADD levels in ganglia were analyzed by Western blotting.
A single 5 min pulse of 5-HT (50 µM), which induces STF
(Ghirardi et al., 1995 ; Mauelshagen et al., 1996 ; Sutton and Carew, 2000 ), did not lead to any change in the PKC phosphorylation of ApADD
in pleural or pedal ganglia immediately after the 5-HT pulse (Table
1A). After five spaced pulses of 5-HT (5 min, 50 µM; 10 min between pulses), which induce LTF
(Montarolo et al., 1986 ; Mauelshagen et al., 1996 ; Sherff and Carew,
1999 ), no change in phospho-ApADD or total ApADD levels was found at 1 hr after initial LTF induction (Fig.
7B; Table 1B). Eighteen hours
after the initial LTF induction, total ApADD levels were also not
changed (Table 1C). In contrast, phospho-ApADD levels were selectively
increased in pleural but not in pedal ganglia (Fig.
7A,B; Table 1C) (unchanged phospho-adducin levels in the pedal ganglia were confirmed using Western blot exposures of various duration). However, changes at distal
SN-MN synapses in the pedal ganglion may have occurred as well but may
have been too small to be detected in pedal homogenate (see
Discussion). In a subset of these experiments (n = 6;
data not shown), the induction of LTF by 5-HT was confirmed with
physiological recording (data kindly provided by C. M. Sherff,
University of California, Irvine, CA). Because there was no difference
in ApADD phosphorylation in this subset of experiments, these data were pooled with the total data set. These results suggest that ApADD phosphorylation at a PKC site may be increased in response to LTF
induction in the presynaptic SNs. The observation that increased ApADD
phosphorylation occurs at a late time point after initial LTF induction
indicates that increased ApADD phosphorylation probably does not
contribute to early but rather to late stages of LTF.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 7.
Adducin phosphorylation in pleural ganglia is
increased 18 hr after initial LTF induction. Pleural-pedal ganglia
were desheathed and continously perfused with ASW. One pleural-pedal
complex from each animal served as a control and was perfused with ASW
only. The pleural-pedal complex from the opposite body side received
five spaced 5 min pulses of 5-HT (50 µM in ASW; 10 min
between pulses) to induce LTF. Pleural and pedal ganglia were
homogenized separately in SDS sample buffer 1 or 18 hr after 5-HT
treatment. Sample processing was as described previously for Figure
3B. A, Coomassie-stained gels and Western
blots from samples taken 18 hr after 5-HT treatment (+) or control
perfusion ( ). B, ApADD and phospho-ApADD levels in
samples were quantified densitometrically from Western blot
autoradiographs. For each sample, phospho-ApADD levels were normalized
to total ApADD levels. Numbers in the histograms indicate the number of
samples in each group. Means were calculated for each treatment and
control groups. The means for the control groups (unstimulated ganglia)
were set to 1. Asterisks indicate means that are significantly
different from the mean of the corresponding control group
(p < 0.05).
|
|
 |
Discussion |
We have identified ApADD, an Aplysia homolog of
mammalian cytoskeletal adducins. ApADD is enriched in the membrane
skeletal region of neurons participating in synaptic facilitation and
is phosphorylated by PKC in vitro and in vivo. In
the intact Aplysia nervous system, ApADD phosphorylation at
a PKC site is increased selectively 18 hr after multiple 5-HT exposures
that give rise to LTF at tail SN-MN synapses (Emptage and Carew, 1993 ;
Mauelshagen et al., 1996 ). These data lead us to propose a model in
which ApADD phosphorylation serves both to destabilize the
actin/spectrin membrane skeleton and permit increased actin
polymerization (see below) (Fig. 8). Both
steps could be critical for structural changes induced by LTF.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 8.
Model of the role of adducins in LTF.
Top, Adducins are regulatory components of the membrane
cytoskeleton. Bottom, Adducins are expressed in neurons,
cross-link actin and spectrin in the cytoskeleton, and cap the
fast-growing barbed end of actin filaments. Induction of LTF with 5-HT
leads to the activation of PKC, an increase in ApADD phosphorylation at
a PKC site, and a weakening of the interaction between ApADD and other
cytoskeletal proteins. This chain of events may both promote
destabilization of actin/spectrin complexes and increase actin
polymerization. Both processes are critical for the initiation of
structural changes accompanying LTF. After the completion of these
changes, dephosphorylation of ApADD induces the stabilization of the
newly remodeled synapse.
|
|
ApADD: a homolog of mammalian adducins
Regions of high similarity to mammalian and Drosophila
adducins are found throughout the entire ApADD deduced amino acid
sequence, suggesting that the overall domain structure for these
proteins is very similar. This similarity in structure is also
supported by the observation that ApADD shows high hydrophilicity in
the region corresponding to the highly hydrophilic C-terminal domain of
mammalian adducins (Joshi et al., 1991 ). Two sites in mammalian adducins have been confirmed as in vivo phosphorylation
sites that modulate adducin function. Phosphorylation of serine 726 in
-adducin by PKC inhibits its actin-capping activity and leads to a
loss of the ability of adducin to recruit spectrin to the cytoskeleton
(Matsuoka et al., 1998 ). In contrast, phosphorylation of threonine 445 by rho kinase enhances F-actin binding of adducin and regulates
membrane ruffling and cell motility of Madin-Darby canine kidney
epithelial cells (Kimura et al., 1998 ; Fukata et al., 1999 ). The region
surrounding threonine 445 of -adducin is highly conserved among
mammalian adducins but less so in ApADD and other invertebrates. In
contrast, the sequence surrounding serine 726 in the MARCKS-related
domain is highly conserved between mammalian adducins, Drosophila
hts R1, and ApADD. This suggests that phosphorylation by PKC may
be a critical modulatory event for adducin function in different
organisms, including Aplysia.
Expression and localization of ApADD
Using antibodies generated against mammalian adducins, we found
that ApADD is widely expressed in Aplysia. This result is again consistent with findings for mammalian - and -adducins and
for Drosophila adducin (Yue and Spradling, 1992 ; Seidel et al., 1995 ; Gilligan et al., 1999 ). In whole-mount preparations of
pleural-pedal ganglia, we detected ApADD immunoreactivity in the
majority of neurons observed. Staining was excluded from nuclei and was
strongest in the submembraneous region of neurons, which is consistent
with a localization of ApADD to the membrane cytoskeleton. Adducin
immunoreactivity has also been detected in hippocampal neurons along
the entire cell membrane, in the cytosol, and in dendrites (Matsuoka et
al., 1998 ). In our preparation, staining was not visible in neurites
but may have been too weak to be detected. It is possible that the
access of the antibody to ApADD may be blocked intracellularly by
cytoskeletal structures within the neurites themselves.
In accordance with a localization to the membrane skeleton, ApADD was
primarily recovered in the particulate fraction of cells that contains
the cytoskeleton and was partially extracted by nonionic detergent like
mammalian adducins (Gardner and Bennett, 1986 ; Dong et al., 1995 ).
These data suggest that ApADD is localized to the membrane skeleton of
Aplysia neurons, including those neurons critically involved
in synaptic facilitation at tail SN-MN synapses.
Functional activation of ApADD
Western blotting experiments using an antibody that was shown to
be specific for the PKC phosphorylation site in mammalian adducins
(Gilligan et al., 2002 ) strongly suggest that ApADD is phosphorylated
in vivo at a PKC site in its C-terminal domain. We found
that this antibody recognizes polypeptides in the Aplysia nervous system that co-migrate with recombinant ApADD and adducins from
red blood cells. In addition, we showed that PKC phosphorylates recombinant proteins in vitro corresponding to ApADD and the
predicted C-terminal domain of ApADD, whereas a protein corresponding
to the predicted N-terminal domain of ApADD was not phosphorylated by
PKC. These findings strongly support our hypothesis that ApADD is
phosphorylated by PKC at a site in its C-terminal domain that corresponds to the in vivo phosphorylation site for PKC in
mammalian adducins. The specificity of the phospho-adducin antibody for PKC phosphorylated ApADD is also supported by experiments on nervous system extract: phosphatase, but not mock treatment of extracts, led to
loss of the signal obtained with the phospho-adducin antibody, whereas
total ApADD as detected with mammalian adducin antibody remained
unchanged. Although our data point to PKC being the kinase responsible
for ApADD phosphorylation, we cannot entirely exclude the possibility
that a different kinase is responsible for its phosphorylation at this site.
Both mammalian adducins and ApADD contain additional predicted
consensus sequences for PKC phosphorylation. However, only one
additional site in mammalian adducins (Ser 716 in human -adducin, Ser703 in -adducin) has been shown to be phosphorylated by PKC in vitro (Matsuoka et al., 1996 ). Because this site is not
conserved in ApADD (or Drosophila adducin), the existence of
additional PKC sites in ApADD is rather unlikely.
Interestingly, basal ApADD phosphorylation in the Aplysia
nervous system is higher than basal adducin phosphorylation in RBCs and
platelets. High levels of phospho-adducin were also detected in
unstimulated rat hippocampus and dentate gyrus (Matsuoka et al., 1998 ).
A high basal level of adducin phosphorylation may be a typical feature
of nervous tissue and could provide a higher degree of regulation of
adducin function by both protein kinases and phosphatases.
We found that phosphorylation of ApADD at a PKC site in the intact
Aplysia nervous system was significantly increased 18 hr, but not 1 hr, after patterns of 5-HT exposure that induce LTF. Interestingly, we found no change in ApADD phosphorylation immediately after a single 5-HT pulse that induces STF. These findings suggest that
PKC phosphorylation of ApADD plays a role in LTF and not in STF. The
data also suggest that ApADD is not involved in the early steps of LTF
induction but rather at a later time in LTF. We found that ApADD
phosphorylation by PKC was increased in the pleural ganglia, which
contain the presynaptic SN cell bodies and proximal SN synapses, but
not in the pedal ganglia, which contain the SN-MN synapses and the
postsynaptic MN cell bodies. Thus, our findings are consistent with the
hypothesis that ApADD phosphorylation by PKC is increased in the
presynaptic SNs that are critical for LTF.
PKC involvement in long-term memory
A role for PKC in intermediate and long-term forms of synaptic
plasticity and memory has been described by several laboratories. For
example, a persistently activated catalytic fragment of PKCzeta [persistently active catalytic fragment (PKM)- ] was recently shown
to be necessary and sufficient for the maintenance of late-phase LTP in
mammalian hippocampus (Ling et al., 2002 ). In Aplysia, a
persistent activation of PKC was detected during intermediate-term sensitization (Sossin et al., 1994 ). More recently, it was shown that
the induction of intermediate-term sensitization by a single tail shock
requires the calpain-dependent proteolysis of PKC, yielding a
persistently active PKM (Sutton et al., 2002 ). In addition, Drier et
al. (2002) recently demonstrated that induction of a PKM transgene
enhanced the formation of long-term memory for olfactory conditioning
in Drosophila. Finally, a persistent activation of PKC in
the time domain of intermediate- and long-term memory was also found
for olfactory conditioning in honeybees (Gruenbaum and Mueller,
1998 ).
In Aplysia, a persistent activation of PKC was detected
during intermediate-term but not long-term facilitation (Sossin et al.,
1994 ). However, these experiments were conducted using a protocol for
the induction of long-term facilitation that differed from ours
(prolonged, 90 min, 5-HT application vs five spaced pulses in our
experiments). Different modes of inducing long-lasting facilitation
have been shown to lead to the recruitment of different signaling
cascades in the sensory neurons of Aplysia (Sutton et al.,
2001 ). In addition, differential activation of signaling pathways has
also been observed in response to different modes of inducing long-term
memory in both Drosophila and honeybee (Tully et al.,
1990 ; Mueller, 1996 ). Therefore, although no PKC activation is
detected during long-term facilitation induced by prolonged 5-HT
application (Sossin et al., 1994 ), long-term PKC activation may well be
induced by spaced applications. Moreover, Sossin et al. (1994) measured
PKC activation as an increase in PKC activity in the particulate
fraction. As these authors point out, this method will reveal only one
possible mode of PKC activation; activation, for example, via
translocation to the cytoskeleton, in which ApADD is localized, or to
the nucleus, would not be detected. Interestingly, it has been shown
recently in Aplysia that the induction of intermediate-term memory for sensitization by a single tail shock requires the
calpain-dependent proteolysis of PKC, yielding a persistently active
and soluble PKM (Sutton et al., 2001 ; Sutton and Carew, 2002 ).
We should also emphasize that the net phosphorylation state of ApADD
will be determined by the competing activities of kinases (PKC) and
phosphatases. Therefore, it is also possible that ApADD phosphorylation
could be triggered initially by PKC activation in the intermediate-term
facilitation (ITF) temporal domain, but could be maintained during LTF
by the downregulation of one or more phosphatases acting on ApADD. Such
a mechanism would allow for increased adducin phosphorylation in the
LTF temporal domain without a concomitant activation of PKC above basal
activity levels.
Several lines of evidence suggest that PKC, like adducins, is
associated with the cytoskeleton. For example, vertebrate
PKC- as well as both Aplysia PKC isoforms have
been demonstrated to bind to actin (Nakhost et al., 1998 ; Prekeris et
al., 1998 ). Moreover, Aplysia PKC Apl II was shown to
colocalize with F-actin in neuronal growth cones (Nakhost et al.,
1998 ). Therefore, we hypothesize that the interaction of PKC with actin
filaments in the membrane cytoskeleton could bring PKC into the
immediate vicinity of cytoskeletal substrates such as ApADD. These
observations are thus consistent with the hypothesis that a form of PKC
that is persistently activated during ITF and possibly LTF could
mediate increased ApADD phosphorylation during LTF.
A possible role of ApADD in long-term synaptic plasticity
An important feature of long-term memory, LTP in the hippocampus,
and LTF in Aplysia is its association with structural
changes at specific synapses (Bailey and Chen, 1988 ; Glanzman et al., 1990 ; Chang et al., 1991 ; Bailey and Kandel, 1994 ; Engert and Bonhoeffer, 1999 ; Klintsova and Greenough, 1999 ; Maletic-Savatic et
al., 1999 ; Bonhoeffer and Yuste, 2002 ). The activation of protein kinases and the induction of gene expression after learning or 5-HT
treatment and the eventual structural changes themselves have been
extensively investigated in Aplysia (Glanzman et al., 1990 ; Bailey and Kandel, 1994 ). However, much less is known about the
connection between increased kinase activities and structural changes.
In Aplysia, an early step in the initiation of structural
changes involves the internalization of the cell-adhesion molecule ApCAM in sensory neurons (Bailey et al., 1992 ; Mayford et al., 1992 ).
This process is thought to lead to a loss of cell-cell contacts and
may remove inhibition for synaptic growth. A second critical event in
structural changes during LTF seems to be actin polymerization, which
contributes to new growth at SN-MN synapses (Hatada et al.,
2000 ). Adducins could contribute to structural changes
associated with LTF and long-term memory in two ways. First, increased
phosphorylation at a PKC site decreases the ability of adducins to
recruit spectrin to actin filaments (Matsuoka et al., 1998 ). Therefore,
increased phosphorylation of ApADD by PKC could lead to loss of
structural rigidity in the membrane cytoskeleton and thereby permit
structural changes associated with LTF to occur. After the
internalization of ApCAM from the SN membrane, this could provide
another permissive step for the initiation of structural changes during
LTF. Second, adducins cap the fast-growing (barbed) end of actin
filaments and thereby block the elongation of actin filaments (Kuhlman
et al., 1996 ). This actin-capping activity is also inhibited by
PKC phosphorylation of adducins (Matsuoka et al., 1998 ). Thus,
increased PKC phosphorylation of ApADD during LTF might lead to a
reduction of actin capping and could thereby allow increased actin
polymerization, which is critical for structural changes associated
with LTF.
Collectively, our data lead us to propose the following model for ApADD
function in LTF (Fig. 8). Induction of LTF leads to a persistent
activation of PKC in the intermediate-term (and perhaps long-term)
temporal domains and, as a consequence, leads to increased phosphorylation of ApADD. This process modulates the interaction of
ApADD with cytoskeletal components and increases both the flexibility of the membrane cytoskeleton and actin polymerization. Both of these
processes could be necessary for structural changes to occur. After the
completion of structural changes, dephosphorylation leads to a
reassociation of ApADD with the membrane cytoskeleton and to an
increase in the capping of actin filaments. Both processes would
promote the stabilization of the newly remodeled synaptic structure.
In conclusion, we have identified a mechanism for rapid and reversible
induction of cytoskeletal modification that may contribute to early
stages of structural remodeling in synaptic modifications accompanying
long-term changes in synaptic strength. These changes could be an
important component of the ultrastructural remodeling underlying
long-term memory.
 |
FOOTNOTES |
Received Sept. 25, 2002; revised Dec. 9, 2002; accepted Dec. 18, 2002.
This work was supported by National Institutes of Health Grant DKHL,
55005-01 (D.M.G.), Simone and Cino Del Luca and Institut National de la
Santé et de la Recherche Médicale Fellowships (S.M.),
Feodor-Lynen Fellowship from the Humboldt Society (L.M.G.), and
National Science Foundation Grant IBN 004-9013 (T.J.C.). We thank
Angela Purcell, Joanna Schaffhausen, Carolyn Sherff, and Michael Sutton
for helpful comments on a previous version of this manuscript.
Correspondence should be addressed to Thomas J. Carew, Department
of Neurobiology and Behavior, Center for Learning and Memory, 2205 BioSciII, University of California, Irvine, Irvine, CA 92697-4550. E-mail: tcarew{at}uci.edu.
 |
References |
-
Audesirk G,
Cabell L,
Kern M
(1997)
Modulation of neurite branching by protein phosphorylation in cultured rat hippocampal neurons.
Dev Brain Res
102:247-260[Medline].
-
Bailey CH,
Chen M
(1988)
Long-term memory in Aplysia modulates the total number of varicosities of single identified sensory neurons.
Proc Natl Acad Sci USA
85:2373-2377[Abstract/Free Full Text].
-
Bailey CH,
Kandel ER
(1994)
Structural changes underlying long-term memory storage in Aplysia: a molecular perspective.
Semin Neurosci
6:35-44.
-
Bailey CH,
Chen M,
Keller F,
Kandel ER
(1992)
Serotonin-mediated endocytosis of apCAM: an early step of learning-related synaptic growth in Aplysia.
Science
256:645-649[Abstract/Free Full Text].
-
Bonhoeffer T,
Yuste R
(2002)
Spine motility: phenomenology, mechanisms, and function.
Neuron
35:1019-1027[Web of Science][Medline].
-
Carew TC,
Castellucci VF,
Kandel ER
(1971)
An analysis of dishabituation and sensitization of the gill-withdrawal reflex in Aplysia.
Int J Neurosci
2:79-98[Medline].
-
Castellucci VF,
Blumenfeld H,
Goelet P,
Kandel ER
(1989)
Inhibitor of protein synthesis blocks long-term behavioral sensitization in the isolated gill-withdrawal reflex of Aplysia.
J Neurobiol
20:1-9[Web of Science][Medline].
-
Chang PL,
Isaacs KR,
Greenough WT
(1991)
Synapse formation occurs in association with the induction of long-term potentiation in two-year-old rat hippocampus in vitro.
Neurobiol Aging
12:517-522[Web of Science][Medline].
-
Dong L,
Chapline C,
Mousseau B,
Fowler L,
Ramsay K,
Stevens JL,
Jaken S
(1995)
35H, a sequence isolated as a protein kinase C binding protein, is a novel member of the adducin family.
J Biol Chem
270:25534-25540[Abstract/Free Full Text].
-
Drier EA,
Tello MK,
Cowan M,
Wu P,
Blace N,
Sacktor TC,
Yin JCP
(2002)
Memory enhancement and formation by atypical PKM activity in Drosophila melanogaster.
Nat Neurosci
5:316-324[Web of Science][Medline].
-
Emptage N,
Carew TC
(1993)
Long-term synaptic facilitation in the absence of short-term facilitation in Aplysia neurons.
Science
262:253-256[Abstract/Free Full Text].
-
Engert F,
Bonhoeffer T
(1999)
Dendritic spine changes associated with hippocampal long-term synaptic plasticity.
Nature
399:66-70[Medline].
-
Frost WN,
Castellucci VF,
Hawkins RD,
Kandel ER
(1985)
Monosynaptic connections from the sensory neurons of the gill- and siphon-withdrawal reflex in Aplysia participate in the storage of long-term memory for sensitization.
Proc Natl Acad Sci USA
82:8266-8269[Abstract/Free Full Text].
-
Fukata Y,
Oshiro N,
Kinoshita N,
Kawano Y,
Matsuoka Y,
Bennett V,
Matsura Y,
Kaibuchi K
(1999)
Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility.
J Cell Biol
145:347-361[Abstract/Free Full Text].
-
Gardner K,
Bennett V
(1986)
A new erythrocyte membrane-associated protein with calmodulin binding activity.
J Biol Chem
261:1339-1348[Abstract/Free Full Text].
-
Gardner K,
Bennett V
(1987)
Modulation of spectrin-actin assembly by erythrocyte adducin.
Nature
328:359-362[Medline].
-
Ghirardi M,
Montarolo PG,
Kandel ER
(1995)
A novel intermediate stage in the transition between short- and long-term facilitation in the sensory to motor neurons synapse of Aplysia.
Neuron
14:413-420[Web of Science][Medline].
-
Gilligan DM,
Lozovatsky L,
Silberfein A
(1997)
Organization of the human beta adducin gene (ADD2).
Genomics
43:141-148[Web of Science][Medline].
-
Gilligan DM,
Lozovatsky L,
Gwynn B,
Brugnara C,
Narla M,
Peters LL
(1999)
Targeted disruption of the beta adducin gene causes spherocytosis in mice.
Proc Natl Acad Sci USA
96:10717-10722[Abstract/Free Full Text].
-
Gilligan DM,
Sarid R,
Weese J
(2002)
Adducin in platelets: activation-induced phosphorylation by PKC and proteolysis by calpain.
Blood
99:2418-2426[Abstract/Free Full Text].
-
Glanzman DL,
Kandel ER,
Schacher S
(1990)
Target-dependent structural changes accompanying long-term synaptic facilitation in Aplysia neurons.
Science
249:4200-4213.
-
Gruenbaum L,
Mueller U
(1998)
Induction of a specific olfactory memory leads to a long-lasting activation of protein kinase C in the antennal lobe of the honeybee.
J Neurosci
18:4384-4392[Abstract/Free Full Text].
-
Hatada Y,
Wu F,
Sun Z-Y,
Schacher S,
Goldberg DJ
(2000)
Presynaptic morphological changes associated with long-term synaptic facilitation are triggered by actin polymerization at preexisting varicosities.
J Neurosci
20:1-5[Abstract/Free Full Text].
-
Hughes CA,
Bennett V
(1995)
Adducin: a physical model with implications for function in assembly of spectrin-actin complexes.
J Biol Chem
270:18990-18996[Abstract/Free Full Text].
-
Joshi R,
Gilligan DM,
Otto E,
McLaughlin T,
Bennett V
(1991)
Primary structure and domain organization of human alpha and beta adducin.
J Cell Biol
115:665-675[Abstract/Free Full Text].
-
Kaiser HW,
O'Keefe E,
Bennett V
(1989)
Adducin: Ca++-dependent association with sites of cell-cell contact.
J Cell Biol
109:557-569[Abstract/Free Full Text].
-
Kimura K,
Fukata Y,
Matsuoka Y,
Bennet V,
Matsuura Y,
Okawa K,
Iwamatsu A,
Kaibuchi K
(1998)
Regulation of the association of adducin with actin filaments by rho-associated kinase (Rho-kinase) and myosin phosphatase.
J Biol Chem
273:5542-5548[Abstract/Free Full Text].
-
Klintsova AY,
Greenough WT
(1999)
Synaptic plasticity in cortical systems.
Curr Opin Neurobiol
9:203-208[Web of Science][Medline].
-
Kuhlman PA,
Hughes CA,
Bennett V,
Fowler VM
(1996)
A new function for adducin: calcium/calmodulin-regulated capping of the barbed ends of actin filaments.
J Biol Chem
271:7986-7991[Abstract/Free Full Text].
-
Levenson J,
Byrne JH,
Eskin A
(1999)
Levels of serotonin in the hemolymph of Aplysia are modulated by light/dark cycles and sensitization training.
J Neurosci
19:8094-8103[Abstract/Free Full Text].
-
Lin B,
Nasir J,
McDonald H,
Graham R,
Rommens JM,
Goldberg YP,
Hayden MR
(1995)
Genomic organization of the human alpha-adducin gene and its alternatively spliced isoforms.
Genomics
25:93-99[Medline].
-
Ling DS,
Benardo LS,
Serrano PA,
Blace N,
Kelly MT,
Crary JF,
Sacktor TC
(2002)
Protein kinase Mzeta is necessary and sufficient for LTP maintenance.
Nat Neurosci
5:295-296[Web of Science][Medline].
-
Maletic-Savatic M,
Malinow R,
Svoboda K
(1999)
Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity.
Science
283:1860-1861[Free Full Text].
-
Marinesco S,
Carew TJ
(2002)
Serotonin release evoked by tail-nerve stimulation in the central nervous system of Aplysia: characterization and relationship to heterosynaptic plasticity.
J Neurosci
22:2229-2312.
-
Martin KC,
Casadio A,
Zhu HEY,
Rose JC,
Chen M,
Bailey CH,
Kandel ER
(1997)
Synapse-specific, long-term facilitation of Aplysia sensory to motor synapses: a function for local protein synthesis in memory storage.
Cell
91:927-938[Web of Science][Medline].
-
Matsuoka Y,
Hughes CA,
Bennett V
(1996)
Adducin regulation. Definition of the calmodulin-binding domain and sites of phosphorylation by protein kinases A and C.
J Biol Chem
271:25157-25166[Abstract/Free Full Text].
-
Matsuoka Y,
Li X,
Bennett V
(1998)
Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons.
J Cell Biol
142:485-497[Abstract/Free Full Text].
-
Mauelshagen J,
Parker G,
Carew TC
(1996)
Dynamics of induction and expression of long-term synaptic facilitation in Aplysia.
J Neurosci
16:7099-7108[Abstract/Free Full Text].
-
Mayford M,
Barzilai A,
Keller F,
Schacher S,
Kandel ER
(1992)
Modulation of a NCAM-related adhesion molecule with long-term synaptic plasticity in Aplysia.
Science
256:638-644[Abstract/Free Full Text].
-
Mische S,
Mooseker M,
Morrow J
(1987)
Erythrocyte adducin: a calmodulin regulated actin-binding protein that stimulates spectrin-actin binding.
J Cell Biol
105:2837-2849[Abstract/Free Full Text].
-
Montarolo PG,
Goelet P,
Castellucci VF,
Morgan J,
Kandel ER,
Schacher S
(1986)
A critical period for macromolecular synthesis in long-term heterosynaptic facilitation in Aplysia.
Science
234:1249-1254[Abstract/Free Full Text].
-
Mueller U
(1996)
Inhibition of nitric oxide synthase impairs a distinct form of long-term memory in the honeybee, Apis mellifera.
Neuron
16:541-549[Web of Science][Medline].
-
Nakhost A,
Forscher P,
Sossin WS
(1998)
Binding of protein kinase C isoforms to actin in Aplysia.
J Neurochem
71:1221-1231[Web of Science][Medline].
-
Pinsker HM,
Hening WA,
Carew TJ,
Kandel ER
(1973)
Long-term sensitization of a defensive withdrawal reflex in Aplysia.
Science
182:1039-1042[Abstract/Free Full Text].
-
Prekeris R,
Hernandez RM,
ayhew MW,
White MK,
Terrain DM
(1998)
Molecular analysis of the interactions between protein kinase C- and filamentous actin.
J Biol Chem
273:26790-26798[Abstract/Free Full Text].
-
Rampon C,
Tang YP,
Goddhouse J,
Shimizu E,
Kyin M,
Tsien JZ
(2000)
Enrichement induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice.
Nat Neurosci
3:205-206[Medline].
-
Sambrook J,
Fritsch EF,
Maniatis T
(1989)
In: Molecular cloning. Plainview, NY: Cold Spring Harbor Laboratory.
-
Sanchez C,
Diaz-Nido J,
Avila J
(2000)
Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function.
Prog Neurobiol
61:133-168[Web of Science][Medline].
-
Seidel B,
Zuschratter W,
Wex H,
Garner CC,
Gundelfinger ED
(1995)
Spatial and sub-cellular localization of the membrane cytoskeleton-associated protein alpha-adducin in the rat brain.
Brain Res
700:13-24[Web of Science][Medline].
-
Sherff CM,
Carew TJ
(1999)
Coincident induction of long-term facilitation in Aplysia: cooperativity between cell bodies and remote synapses.
Science
285:1911-1914[Abstract/Free Full Text].
-
Sinard JH,
Stewart GW,
Stabach PR,
Argent AC,
Gilligan DM,
Morrow JS
(1998)
Utilization of an 86 bp exon generates a novel adducin isoform (beta4) lacking the MARCKS homology domain.
Biochim Biophys Acta
1396:57-66[Medline].
-
Sossin WS,
Sacktor TC,
Schwartz JH
(1994)
Persistent activation of protein kinase C during the development of long-term facilitation in Aplysia.
Learn Mem
1:189-202[Abstract/Free Full Text].
-
Suriyapperuma S,
Lozovatsky L,
Ciciotte SL,
Peters LL,
Gilligan DM
(2000)
The murine adducin gene family: alternative splicing and chromosomal localization.
Mamm Genome
11:16-23[Web of Science][Medline].
-
Sutton MA,
Carew TJ
(2000)
Parallel molecular pathways mediate expression of distinct forms of intermediate-term facilitation at tail sensory-motor synapses in Aplysia.
Neuron
26:219-231[Web of Science][Medline].
-
Sutton MA,
Carew TJ
(2002)
Behavioral, cellular and molecular analysis of memory in Aplysia I: Intermediate-term memory.
Integ Comp Biol
42:725-735.
-
Sutton MA,
Bagnall MW,
Carew TJ
(2001)
Molecular mechanisms of site-specific memory for sensitization in Aplysia.
Soc Neurosci Abstr
965:12.
-
Toni N,
Buchs PA,
Nikenko I,
Bron CR,
Muller D
(1999)
LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite.
Nature
402:421-425[Medline].
-
Tully T,
Boynton S,
Brandes C,
Dura JM,
Mihalek R,
Preat T,
Villella A
(1990)
Genetic dissection of memory formation in Drosophila melanogaster.
Cold Spring Harb Symp Quant Biol
55:203-211[Abstract/Free Full Text].
-
Wainwright ML,
Zhang H,
Byrne JH,
Cleary LJ
(2002)
Localized neuronal outgrowth induced by long-term sensitization training in Aplysia.
J Neurosci
22:4132-4141[Abstract/Free Full Text].
-
Waseem A,
Palfrey HC
(1988)
Erythrocyte adducin.
Eur J Biochem
178:563-573[Medline].
-
Waseem A,
Palfrey HC
(1990)
Identification and protein kinase C-dependent phosphorylation of alpha-adducin in human fibroblasts.
J Cell Sci
96:93-98[Abstract/Free Full Text].
-
Yue L,
Spradling AC
(1992)
hu-li tai shao, a gene required for ring canal formation during Drosophila oogenesis, encodes a homolog of adducin.
Genes Dev
6:2443-2454[Abstract/Free Full Text].
Copyright © 2003 Society for Neuroscience 0270-6474/03/2372675-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
J.-Y. Hu, Y. Chen, and S. Schacher
Protein Kinase C Regulates Local Synthesis and Secretion of a Neuropeptide Required for Activity-Dependent Long-Term Synaptic Plasticity
J. Neurosci.,
August 15, 2007;
27(33):
8927 - 8939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Rabenstein, N. A. Addy, B. J. Caldarone, Y. Asaka, L. M. Gruenbaum, L. L. Peters, D. M. Gilligan, R. M. Fitzsimonds, and M. R. Picciotto
Impaired Synaptic Plasticity and Learning in Mice Lacking {beta}-Adducin, an Actin-Regulating Protein
J. Neurosci.,
February 23, 2005;
25(8):
2138 - 2145.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|